Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder
Kristi L. Stringer, Kirsten J. Langdon, Michelle McKenzie, Brad Brockmann, Phillip Marotta
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Opioid use disorder2019-20 coronavirus outbreakFlexibility (engineering)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Opioid epidemicOpioidMEDLINECoronavirus InfectionsMedicinePsychiatryVirologyPolitical scienceInternal medicineEconomicsDiseaseOutbreakReceptorInfectious disease (medical specialty)LawManagementOpioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesTreatment of Major Depression